CAJ | 학술논문

目的：总结麦默通手术病例，探讨乳腺肿物麦默通旋切术的操作经验。方法使用美国强生公司的麦默通微创旋切系统，在西门子彩超X150引导下对600例乳腺肿物患者行麦默通微创切除术，肿物切除后均送病理检查，并对患者进行术后1个月、3个月及6个月的随访。结果600例患者中，包括良性纤维腺瘤的508例，纤维囊性增生症22例，乳腺腺病51例，导管内乳头状瘤6例，浸润性乳腺癌8例，积乳5例。8例确诊为乳腺癌患者中，6例接受改良根治术，2例行保乳根治术。术中2例发现活动性出血，切开止血后痊愈；5例术后发生局部血肿，1例切开清除血肿，另外4例经抽吸血肿后加压包扎；皮下淤血9例，切破皮肤1例。510例得到随访，其中502例良性病变中，发现新发良性肿物5例，1例复发；8例诊断为乳腺癌患者，经规范治疗后随诊未见复发转移。结论麦默通微创旋切术对于良性乳腺肿物的切除是安全可行的，对于恶性肿物的活检提供了足量的病理标本，有助于明确诊断及进一步治疗。
목적：총결맥묵통수술병례，탐토유선종물맥묵통선절술적조작경험。방법사용미국강생공사적맥묵통미창선절계통，재서문자채초X150인도하대600례유선종물환자행맥묵통미창절제술，종물절제후균송병리검사，병대환자진행술후1개월、3개월급6개월적수방。결과600례환자중，포괄량성섬유선류적508례，섬유낭성증생증22례，유선선병51례，도관내유두상류6례，침윤성유선암8례，적유5례。8례학진위유선암환자중，6례접수개량근치술，2례행보유근치술。술중2례발현활동성출혈，절개지혈후전유；5례술후발생국부혈종，1례절개청제혈종，령외4례경추흡혈종후가압포찰；피하어혈9례，절파피부1례。510례득도수방，기중502례량성병변중，발현신발량성종물5례，1례복발；8례진단위유선암환자，경규범치료후수진미견복발전이。결론맥묵통미창선절술대우량성유선종물적절제시안전가행적，대우악성종물적활검제공료족량적병리표본，유조우명학진단급진일보치료。
Objective To summarize experience in clinical practice of breast tunors by using ultrasound-guided Mammotome system. Methods 600 patients with breast lesions underwent the tumor resection by Mammotome biopsy system (Johnson & Johnson US) and Siemens Ultrasound X150 from April 2012 to August 2013. The patients were followed up in one month, three months and six months after operation. Results Of the 600 cases, benign fibroadenoma was in 508 cases, benign fibrocystic breast disease in 22,.adenosis of breast in 51,.intraductal papilloma in 6,.milk product in 5, invasive breast carcinoma in 8..In the breast carcinoma patients,.6 cases underwent modified radical mastectomy , 2 received breast conserving treatment..In postoperative complications,.active bleeding occurred in 2 cases and underwent second operation,.hematoma formation was found in 5 cases and treated by aspiration, large subcutaneous congestion was found in 9 cases and recovered by conservative treatment except incision and drainage..A total of 510 patients were followed up,.in which 5 were found new tumor,.1 relapsed..None of the breast cancer patients were found recurrence and metastasis. Conclusion Mammotome atherectomy is safe and feasible for the benign breast tumor , and it can provide enough pathological specimens for the diagnosis and further treatment of the malignant tumor.